IBDEI0H7 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23248,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,23248,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,23249,0)
 ;;=397.1^^127^1420^74
 ;;^UTILITY(U,$J,358.3,23249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23249,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,23249,1,5,0)
 ;;=5^Rheumatic Disease Pulmonary Valve
 ;;^UTILITY(U,$J,358.3,23249,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,23250,0)
 ;;=397.0^^127^1420^75
 ;;^UTILITY(U,$J,358.3,23250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23250,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,23250,1,5,0)
 ;;=5^Rheumatic Disease Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,23250,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,23251,0)
 ;;=414.3^^127^1420^17
 ;;^UTILITY(U,$J,358.3,23251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23251,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,23251,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,23251,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,23252,0)
 ;;=414.4^^127^1420^16
 ;;^UTILITY(U,$J,358.3,23252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23252,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,23252,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,23252,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,23253,0)
 ;;=425.11^^127^1420^60
 ;;^UTILITY(U,$J,358.3,23253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23253,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,23253,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,23253,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,23254,0)
 ;;=425.18^^127^1420^59
 ;;^UTILITY(U,$J,358.3,23254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23254,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,23254,1,5,0)
 ;;=5^Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,23254,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,23255,0)
 ;;=V12.55^^127^1420^54
 ;;^UTILITY(U,$J,358.3,23255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23255,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,23255,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,23255,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,23256,0)
 ;;=454.9^^127^1420^84
 ;;^UTILITY(U,$J,358.3,23256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23256,1,4,0)
 ;;=4^454.9
 ;;^UTILITY(U,$J,358.3,23256,1,5,0)
 ;;=5^Varicose Veins
 ;;^UTILITY(U,$J,358.3,23256,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,23257,0)
 ;;=271.3^^127^1421^11
 ;;^UTILITY(U,$J,358.3,23257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23257,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,23257,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,23257,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,23258,0)
 ;;=611.1^^127^1421^16
 ;;^UTILITY(U,$J,358.3,23258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23258,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,23258,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,23258,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,23259,0)
 ;;=704.1^^127^1421^17
 ;;^UTILITY(U,$J,358.3,23259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23259,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,23259,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,23259,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,23260,0)
 ;;=251.2^^127^1421^30
 ;;^UTILITY(U,$J,358.3,23260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23260,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,23260,1,5,0)
 ;;=5^Hypoglycemia NOS
 ;;^UTILITY(U,$J,358.3,23260,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,23261,0)
 ;;=253.2^^127^1421^34
 ;;^UTILITY(U,$J,358.3,23261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23261,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,23261,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,23261,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,23262,0)
 ;;=733.00^^127^1421^43
 ;;^UTILITY(U,$J,358.3,23262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23262,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,23262,1,5,0)
 ;;=5^Osteoporosis NOS
 ;;^UTILITY(U,$J,358.3,23262,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,23263,0)
 ;;=278.00^^127^1421^40
 ;;^UTILITY(U,$J,358.3,23263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23263,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,23263,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,23263,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,23264,0)
 ;;=278.01^^127^1421^39
 ;;^UTILITY(U,$J,358.3,23264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23264,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,23264,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,23264,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,23265,0)
 ;;=250.80^^127^1421^10
 ;;^UTILITY(U,$J,358.3,23265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23265,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,23265,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,23265,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,23266,0)
 ;;=250.00^^127^1421^5
 ;;^UTILITY(U,$J,358.3,23266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23266,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,23266,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,23266,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,23267,0)
 ;;=250.40^^127^1421^6
 ;;^UTILITY(U,$J,358.3,23267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23267,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,23267,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,23267,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,23268,0)
 ;;=250.50^^127^1421^9
 ;;^UTILITY(U,$J,358.3,23268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23268,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,23268,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,23268,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,23269,0)
 ;;=250.60^^127^1421^7
 ;;^UTILITY(U,$J,358.3,23269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23269,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,23269,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,23269,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,23270,0)
 ;;=250.70^^127^1421^8
 ;;^UTILITY(U,$J,358.3,23270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23270,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,23270,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,23270,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,23271,0)
 ;;=250.01^^127^1421^4
 ;;^UTILITY(U,$J,358.3,23271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23271,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,23271,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,23271,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,23272,0)
 ;;=272.0^^127^1421^22
 ;;^UTILITY(U,$J,358.3,23272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23272,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,23272,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,23272,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,23273,0)
 ;;=272.1^^127^1421^28
 ;;^UTILITY(U,$J,358.3,23273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23273,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,23273,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,23273,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,23274,0)
 ;;=272.2^^127^1421^24
 ;;^UTILITY(U,$J,358.3,23274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23274,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,23274,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,23274,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,23275,0)
 ;;=275.42^^127^1421^21
 ;;^UTILITY(U,$J,358.3,23275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23275,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,23275,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,23275,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,23276,0)
 ;;=275.41^^127^1421^29
 ;;^UTILITY(U,$J,358.3,23276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23276,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,23276,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,23276,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,23277,0)
 ;;=276.7^^127^1421^23
 ;;^UTILITY(U,$J,358.3,23277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23277,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,23277,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,23277,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,23278,0)
 ;;=275.2^^127^1421^19
 ;;^UTILITY(U,$J,358.3,23278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23278,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,23278,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,23278,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,23279,0)
 ;;=276.0^^127^1421^25
 ;;^UTILITY(U,$J,358.3,23279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23279,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,23279,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,23279,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,23280,0)
 ;;=276.1^^127^1421^32
 ;;^UTILITY(U,$J,358.3,23280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23280,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,23280,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,23280,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,23281,0)
 ;;=275.3^^127^1421^20
 ;;^UTILITY(U,$J,358.3,23281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23281,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,23281,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,23281,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,23282,0)
 ;;=240.0^^127^1421^14
 ;;^UTILITY(U,$J,358.3,23282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23282,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,23282,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,23282,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,23283,0)
 ;;=241.1^^127^1421^13
 ;;^UTILITY(U,$J,358.3,23283,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23283,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,23283,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,23283,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,23284,0)
 ;;=241.0^^127^1421^50
 ;;^UTILITY(U,$J,358.3,23284,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23284,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,23284,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,23284,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,23285,0)
 ;;=242.00^^127^1421^15
 ;;^UTILITY(U,$J,358.3,23285,1,0)
 ;;=^358.31IA^5^2
